About Us

The network is crucial in making a difference in the lives of people with HS. As a patient advocate and patient, sitting back not doing anything was not an option. I hope the network makes an impact by improving the wellness of people living with HS.

A board-certified dermatologist from India. Dr. Kaur completed her medical degree and dermatology residency training at Baba Farid University of Health Sciences, India. She has more than 10 years of clinical dermatology experience before moving to the USA and is currently working as a research fellow at Ohio State University. Her research is focused on new treatment modalities for HS to improve disease and patient-reported outcomes and the impact of different treatments on the quality of life in patients with HS. Dr. Kaur is passionate about patient education and clinical outcomes research. She has published numerous papers in renowned medical journals as a lead author and presented her work at national and international dermatology conferences. With more than a decade of experience in dermatology and a solid background in clinical practice and research, Dr. Kaur brings invaluable insights as a board member. She shares her knowledge about the disease, available treatments, and challenges patients experience and supports the organization’s advocacy efforts. She lives in Columbus, Ohio, with her husband and two kids. Outside work, her interests include cooking, yoga, dance, and volunteering in her community. As a board member, Dr. Kaur is committed to advancing the IAHSN mission by increasing HS awareness and education while facilitating research and collaboration.

Medical student at Duke University School of Medicine (Class of 2026). Her fascination regarding the combination of immune dysregulation and microbial dysbiosis that contributes to HS pathogenesis is what led her to pursue research in HS. She is currently conducting a PeDRA-funded study to investigate the drug survival of biologic therapies in pediatric patients with HS. As Secretary of the IAHSN, she works with the Board of Directors to increase HS awareness and advocate for HS patients. Her future goals include establishing an HS specialty clinic to facilitate earlier diagnosis and treatment of HS and continuing the pursuit of novel treatments to minimize HS morbidity.